Sign up with Facebook
- Health A to Z
- Healthy Living
News: February 14, 2012
Heart Disease May Be Risk Factor for Prostate Cancer
THURSDAY, Feb. 9 (HealthDay News) -- Heart disease may be a risk factor for prostate cancer, a new study suggests. If this link is confirmed in future research, it means that lifestyle changes that reduce heart disease risk -- such as weight loss,...
Science Shows How Exercise Might Help in Prostate Cancer
TUESDAY, Jan. 31 (HealthDay News) -- Vigorous exercise causes changes in some 180 prostate genes among men with early stage prostate cancer, a new study suggests. Included are genes known to suppress tumor growth and repair DNA, which might mean t...
Experimental Drugs Do Battle Against Advanced Prostate Cancer
TUESDAY, Jan. 31 (HealthDay News) -- Two new drugs, taken alone or potentially together, may boost survival for men with advanced prostate cancer, studies suggest. The results were so promising that both trials were stopped early to make sure all ...
Study Compares 3 Common Prostate Cancer Treatments
TUESDAY, Jan. 31 (HealthDay News) -- Experts comparing three leading prostate cancer therapies find external beam radiation therapy to be more toxic and expensive than either surgery or a more localized form of radiation therapy known as brachythe...
Drug May Slow Early Prostate Cancer: Study
TUESDAY, Jan. 24 (HealthDay News) -- New research suggests that Avodart, a drug used to treat an enlarged prostate gland, may help slow the progression of early stage prostate cancer, reducing the need for aggressive treatment in some men. Prostat...
Making Sense of Cancer Screening Updates
TUESDAY, Dec. 20 (HealthDay News) -- As experts alter course on guidelines for cancer screenings such as mammograms and the prostate-specific antigen test, the general public is understandably confused. Women at age 40 wonder if they should have a...
Could Women's Use of 'the Pill' Raise Men's Prostate Cancer Risk?
MONDAY, Nov. 14 (HealthDay News) -- With the vast increase in the use of the contraceptive pill over the past 40 years, the amount of estrogen entering the water supply may be partly responsible for the increased incidence of prostate cancer aroun...
Radiation Plus Hormone Therapy Extends Life in High-Risk Prostate Cancer
WEDNESDAY, Nov. 2 (HealthDay News) -- A combination of radiation and hormone therapy prolongs survival among men whose cancer has spread beyond the prostate, Canadian and U.K. researchers report. These men have what is called high-risk, or locally...
Panel's Rejection of PSA Test Spurs Mixed Reaction From Experts
FRIDAY, Oct. 7 (HealthDay News) -- News that a key government advisory panel will give a thumbs-down next week to a controversial blood test for prostate cancer is garnering both praise and condemnation from experts. A draft report due out early n...
Report: Task Force to Recommend Against PSA Test
THURSDAY, Oct. 6 (HealthDay News) -- The U.S. Preventive Services Task Force is preparing to recommend that men no longer get screened for prostate cancer by undergoing prostate specific antigen -- or PSA -- testing, CNN reported Thursday evening,...
U.S. Scientists Map Genome of Advanced Prostate Cancer
TUESDAY, Sept. 27 (HealthDay News) -- A number of recurrent genetic errors common to advanced lethal prostate cancers have been identified by scientists who conducted the first complete genome mapping of these types of cancers. The team also ident...
Couples Counseling Boosts Sex Lives After Prostate Cancer
MONDAY, Sept. 26 (HealthDay News) -- The side effects of prostate cancer treatments, including surgery and radiation, can seriously disrupt a couple's sex life. But a new study finds that counseling helped married men and women figure out what sor...
Five Genes May Be Tied to Lethal Prostate Cancer
TUESDAY, Aug. 16 (HealthDay News) -- In what may be a diagnostic advance, U.S. and Swedish researchers have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. The findings co...
Urine Test Might Help Predict Prostate Cancer Risk
WEDNESDAY, Aug. 3 (HealthDay News) -- A new urine test might help doctors detect prostate cancer and better evaluate a patient's treatment options, researchers say. "This is a tool that men and their physician can use to help them decide whether i...
Medicare Will Pay for Prostate Cancer Drug
THURSDAY, June 30 (HealthDay News) -- The cost of Provenge, an expensive and newly approved therapeutic prostate cancer vaccine, will be covered by Medicare for men with metastatic prostate cancer, the agency announced late Thursday. The vaccine, ...
Experimental Vaccine Seems to Cure Prostate Cancer in Mice
SUNDAY, June 19 (HealthDay News) -- Preliminary research shows that an experimental vaccine may cure prostate cancer in mice. Unlike previous cancer vaccine attempts, the new prostate cancer vaccine appears to be smart enough to outfox prostate ca...
Drugs for Enlarged Prostate May Raise Risk of Aggressive Cancer
THURSDAY, June 9 (HealthDay News) -- The U.S. Food and Drug Administration is calling for new warning labels on a class of drugs used primarily to treat enlarged prostates, because the medications may raise the risk of developing an aggressive for...
New Drug Extends Survival for Men With Advanced Prostate Cancer
THURSDAY, May 26 (HealthDay News) -- For men with advanced hormone-resistant prostate cancer who have also failed chemotherapy, the new drug Zytiga (abiraterone acetate) along with the steroid prednisone appears to boost survival, researchers repo...
Regular Brisk Walks May Protect Prostate Cancer Patients
MONDAY, May 23 (HealthDay News) -- Prostate cancer patients who take brisk walks on a regular basis fare better than those who don't, a new study suggests. They not only lower their risk for disease progression, they lower their chances of dying f...
Earlier PSA Test Best Predicts Risk of Dying From Prostate Cancer: Study
WEDNESDAY, May 18 (HealthDay News) -- The results of a first prostate-specific antigen (PSA) test for males between the ages of 44 and 50 can predict the risk of dying of prostate cancer within the next 25 to 30 years, according to a new study. Re...
Surgery Viable for Advanced Prostate Cancer, Study Finds
TUESDAY, May 17 (HealthDay News) -- Surgery to remove the prostate gland (radical prostatectomy) led to a 20-year survival rate for 80 percent of patients with advanced prostate cancer, a new study finds. The study included patients with cancer th...
New Drug Extends Life a Bit in Advanced Prostate Cancer
MONDAY, May 16 (HealthDay News) -- For men with advanced hormone-resistant prostate cancer who have also failed chemotherapy, the new drug Zytiga (abiraterone acetate) along with the steroid prednisone appears to increase survival modestly, a new ...
PSA Test Could Be Improved to Spot Prostate Cancer
MONDAY, May 16 (HealthDay News) -- Amid the controversy swirling around the value of PSA testing as a screen for prostate cancer, new evidence emerges that there may be ways to fine-tune the screening so it benefits more men, while avoiding unnece...
Prostate Cancer Survival May Be Especially Tough on Gay Men
MONDAY, May 16 (HealthDay News) -- Gay men have a lower health-related quality of life than other men after prostate cancer treatment, a new study finds. The study included 92 gay men in the United States and Canada who completed an Internet surve...
Zytiga Approved for Advanced Prostate Cancer
FRIDAY, April 29 (HealthDay News) -- Zytiga (abiraterone acetate), used in combination with the steroid prednisone, has been approved to treat advanced prostate cancer, the U.S. Food and Drug Administration said in a news release. The growth of ca...
Acupuncture May Help Ease Hot Flashes Tied to Prostate Cancer Treatment
MONDAY, April 25 (HealthDay News) -- Acupuncture might help reduce the hot flashes that frequently affect prostate cancer patients while they're on hormone therapy, a small study suggests. The findings don't confirm that the ancient Chinese discip...
Prostate Cancer Screening Doesn't Cut Death Rates: Study
THURSDAY, March 31 (HealthDay News) -- A 20-year study from Sweden suggests that screening for prostate cancer does not substantially reduce the risk of death from the disease. On the other hand, a good many men might receive false-positive result...
Short Course of Hormone Therapy Boosts Prostate Cancer Survival: Study
THURSDAY, March 24 (HealthDay News) -- Just six months of hormone therapy, along with radiation, cuts the risk of dying from locally advanced prostate cancer in half when compared to radiation alone, researchers report. Just as important, the stud...
Newer Drug May Help Prevent Fracture in Men With Prostate Cancer
WEDNESDAY, Feb. 23 (HealthDay News) -- A new drug called denosumab (Xgeva) performed somewhat better than the current standard treatment of zoledronic acid (Zometa) for preventing fractures and other bone problems in men with hormone-resistant pro...
PSA Test Cut-off Could Signal Low-Risk Prostate Cancer
TUESDAY, Feb. 15 (HealthDay News) -- Men who have a low prostate-specific antigen (PSA) score when they're first tested may not need to be screened annually and probably don't need to undergo a biopsy, a new study suggests. Dutch researchers prese...
Could Hair Loss at 20 Signal Higher Prostate Cancer Risk?
TUESDAY, Feb. 15 (HealthDay News) -- Men with prostate cancer may be twice as likely to have started showing signs of male pattern baldness at the age of 20 than those without prostate cancer, a new French study suggests. Men who start losing thei...
First Look at Prostate Cancer Genome Yields Insights
WEDNESDAY, Feb. 9 (HealthDay News) -- Genetic sequencing of the entire prostate cancer cell genome revealed never-before-seen changes in DNA that may contribute to tumor growth, new research finds. By mapping the full genetic blueprint of the tumo...
Exercise May Improve Odds Against Prostate Cancer Death
WEDNESDAY, Jan. 5 (HealthDay News) -- Prostate cancer patients who routinely engage in modest amounts of vigorous physical exercise appear to lower their risk of dying from their disease, new research suggests. Three hours a week or more of vigoro...
Scientists Find Protein That May Help Control Prostate Cancer
FRIDAY, Dec. 3 (HealthDay News) -- A protein that regulates prostate stem cell self-renewal and also plays a role in the transformation of healthy cells into prostate cancer cells has been identified by U.S. scientists. The findings, which involve...
FDA Panel Votes Against Drugs Said to Prevent Prostate Cancer
WEDNESDAY, Dec. 1 (HealthDay News) -- A U.S. Food and Drug Administration advisory committee on Wednesday voted against approving two drugs for the prevention of prostate cancer, the third-highest cancer killer of men. The panel voted 17-0, with o...
FDA Panel to Vote on Drugs Said to Prevent Prostate Cancer
WEDNESDAY, Dec. 1 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel is expected to decide Wednesday whether to approve two drugs for the prevention of prostate cancer, the third highest cancer killer of men. Avodart and Prosca...
Fracture Risk Seen With Hormone Therapy for Prostate Cancer
TUESDAY, Nov. 9 (HealthDay News) -- Long-term use of androgen deprivation therapy to treat prostate cancer may increase older patients' risk of broken bones, according to a new study. These findings suggest that careful consideration is needed bef...
PSA Test Reduces Risk of Spread if Prostate Cancer Strikes
MONDAY, Oct. 25 (HealthDay News) -- Having a prostate-specific antigen (PSA) test to screen for prostate cancer reduces the risk that if cancer develops it will spread to other parts of the body, new research indicates. The finding adds to the ong...
Common Prostate Cancer Treatment Linked to Bone Decay
FRIDAY, Oct. 8 (HealthDay News) -- A common prostate cancer treatment called androgen deprivation therapy (ADT) is associated with bone decay, according to a new study. The therapy suppresses or blocks the production of male sex hormones that cont...
Gene Variations Appear Linked to Prostate Cancer, Study Finds
THURSDAY, Oct. 7 (HealthDay News) -- Variations in a gene for an enzyme involved in cell energy metabolism may increase the risk of prostate cancer, say scientists. These genetic variations impair the enzyme phosphodiesterase 11A (PDE11A), which h...
Experimental Test May Spot Prostate Cancer Earlier, More Accurately
TUESDAY, Sept. 28 (HealthDay News) -- A new blood test to spot a cluster of specific proteins may indicate the presence of prostate cancer more accurately and earlier than is now possible, new research suggests. The test, which has thus far only b...
Surgery a Help for Aggressive Prostate Cancer: Study
MONDAY, Sept. 27 (HealthDay News) -- Patients battling the most aggressive form of prostate cancer are good candidates for prostate surgery, and it could extend their lives, new research indicates. A team of researchers from the Mayo Clinic in Roc...
Uninsured With Prostate Cancer Diagnosed With More Advanced Disease
FRIDAY, Sept. 17 (HealthDay News) -- Prostate cancer patients who are uninsured or on Medicaid at the time of their diagnosis tend to have more severe disease, likely because they have less access to medical care, U.S. researchers report. They ana...
Men With Low PSA at 60 Might Not Need Further Screening
WEDNESDAY, Sept. 15 (HealthDay News) -- Fresh on the heels of a similar report released earlier this week, a new study shows that men who have a low prostate-specific antigen (PSA) level at 60 do not really need future screening. Conversely, men w...
Prostate Cancer Screening No Benefit to Older Men With Low PSA Levels
MONDAY, Sept. 13 (HealthDay News) -- Although many men are concerned about prostate cancer, a new study finds that in men aged 55 to 74 with low levels of baseline prostate-specific antigen (PSA), further screening and early detection of prostate ...
Initial Savings May Hide True Cost of Prostate Cancer Care
MONDAY, Aug. 23 (HealthDay News) -- The initial treatment given to prostate cancer patients has a major impact on short- and long-term costs of care, a new study has found. For example, while some may opt for an initial treatment that is less expe...
Docs Shying Away From Drug That May Prevent Prostate Cancer
THURSDAY, Aug. 12 (HealthDay News) -- Even though a major study found that the drug finasteride could reduce the risk of prostate cancer by 25 percent, it is still not being widely prescribed for that purpose, Veterans Administration researchers r...
Statins, Painkillers May Upset PSA Test Results
FRIDAY, Aug. 6 (HealthDay News) -- Some of the most widely prescribed drugs in the United States may skew results of prostate cancer screening tests, possibly causing errors in diagnoses, a new study finds. A prostate cancer diagnosis is typically...
PSA Test Does Cut Prostate Cancer Deaths, Study Finds
WEDNESDAY, June 30 (HealthDay News) -- Adding to the ongoing debate on the usefulness of the prostate-specific antigen (PSA) blood test for prostate cancer, new research from Sweden finds the screen cuts lives lost to the disease by almost half. T...
Statins May Lower Rates of Prostate Cancer Recurrence
MONDAY, June 28 (HealthDay News) -- A new study suggests that men who take the cholesterol-lowering drugs known as statins are a third less likely to suffer from recurrences of prostate cancer. But don't demand that your doctor prescribe a statin ...
Advertisement
